These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16276163)

  • 1. Intralesional methotrexate for keratoacanthoma of the nose.
    Cohen PR; Schulze KE; Teller CF; Nelson BR
    Skinmed; 2005; 4(6):393-5. PubMed ID: 16276163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional methotrexate in keratoacanthoma of the nose.
    Hurst LN; Gan BS
    Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional methotrexate as non-surgical therapy for giant keratoacanthoma on the nose.
    Sayan A; Taibjee S; Ilankovan V
    Br J Oral Maxillofac Surg; 2024 Feb; 62(2):203-205. PubMed ID: 38267280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically].
    Remling R; Mempel M; Schnopp N; Abeck D; Ring J
    Hautarzt; 2000 Aug; 51(8):612-4. PubMed ID: 10997318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
    Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
    Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report.
    de Visscher JG; van der Wal KG; Blanken R; Willemse F
    J Oral Maxillofac Surg; 2002 Jan; 60(1):93-5. PubMed ID: 11757016
    [No Abstract]   [Full Text] [Related]  

  • 7. Intralesional methotrexate in solitary keratoacanthoma.
    Cuesta-Romero C; de Grado-Peña J
    Arch Dermatol; 1998 Apr; 134(4):513-4. PubMed ID: 9580539
    [No Abstract]   [Full Text] [Related]  

  • 8. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
    Nofal A; Alakad R; Wahid R; Hoseiny HAM
    Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
    Aubut N; Alain J; Claveau J
    J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
    Moss M; Weber E; Hoverson K; Montemarano AD
    Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eruptive Keratoacanthomas in a Red Tattoo.
    Linares-Gonzalez L; Ródenas-Herranz T; Galvez-Moreno M; Ruiz-Villaverde R
    Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e372-e373. PubMed ID: 33110656
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of a recurrent keratoacanthoma with oral isotretinoin.
    Wong WY; Kolbusz RV; Goldberg LH; Guana A
    Int J Dermatol; 1994 Aug; 33(8):579-83. PubMed ID: 7960358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancytopenia after treatment of keratoacanthoma by single lesional methotrexate infiltration.
    Goebeler M; Lurz C; Kolve-Goebeler ME; Bröcker EB
    Arch Dermatol; 2001 Aug; 137(8):1104-5. PubMed ID: 11493112
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
    Doerfler L; Hanke CW
    J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
    Hoegler KM; Schleichert RA
    J Am Acad Dermatol; 2020 Nov; 83(5):1542-1543. PubMed ID: 32622139
    [No Abstract]   [Full Text] [Related]  

  • 18. Aggressive giant keratoacanthoma of the face treated with intramuscular methotrexate and triamcinolone acetonide.
    Santoso-Pham JC; Shelley ED; Shelley WB
    Cutis; 1997 Jun; 59(6):329-32. PubMed ID: 9218892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratoacanthoma-Like Growths of Incontinentia Pigmenti Successfully Treated with Intralesional Methotrexate.
    Barros B; Helm K; Zaenglein A; Seiverling E
    Pediatr Dermatol; 2017 Jul; 34(4):e203-e204. PubMed ID: 28414858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional therapy for the treatment of keratoacanthoma.
    Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
    Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.